The Molecular Basis for Apolipoprotein E4 as the Major Risk Factor for Late-Onset Alzheimer's Disease

被引:30
|
作者
Raulin, Ana-Caroline [1 ]
Kraft, Lucas [2 ]
Al-Hilaly, Youssra K. [1 ,5 ]
Xue, Wei-Feng [3 ]
McGeehan, John E. [4 ]
Atack, John R. [2 ,6 ]
Serpelll, Louise [1 ]
机构
[1] Univ Sussex, Sch Life Sci, Sussex Neurosci, Brighton BN1 6NN, E Sussex, England
[2] Univ Sussex, Sch Life Sci, Sussex Drug Discovery Ctr, Brighton BN1 6NN, E Sussex, England
[3] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England
[4] Univ Portsmouth, Fac Sci, Inst Biol & Biomed Sci, Sch Biol Sci, Portsmouth PO1 2DY, Hants, England
[5] Mustansiriyah Univ, Coll Sci, Chem Dept, Baghdad, Iraq
[6] Cardiff Univ, Med Discovery Inst, Cardiff CF10 3AT, S Glam, Wales
基金
英国生物技术与生命科学研究理事会;
关键词
apolipoprotein E; Alzheimer's disease; small-angle x-ray scattering; analytical ultracentrifugation; alpha-helix; PROTEIN SECONDARY STRUCTURE; RAY FIBER DIFFRACTION; X-RAY; AMYLOID FIBRILS; TERMINAL DOMAIN; A-BETA; APOE; PEPTIDE; E3; E2;
D O I
10.1016/j.jmb.2019.04.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apolipoprotein E4 (ApoE4) is one of three (E2, E3 and E4) human isoforms of an alpha-helical, 299-amino-acid protein. Homozygosity for the epsilon 4 allele is the major genetic risk factor for developing late-onset Alzheimer's disease (AD). ApoE2, ApoE3 and ApoE4 differ at amino acid positions 112 and 158, and these sequence variations may confer conformational differences that underlie their participation in the risk of developing AD. Here, we compared the shape, oligomerization state, conformation and stability of ApoE isoforms using a range of complementary biophysical methods including small-angle x-ray scattering, analytical ultracentrifugation, circular dichroism, x-ray fiber diffraction and transmission electron microscopy We provide an indepth and definitive study demonstrating that all three proteins are similar in stability and conformation. However, we show that ApoE4 has a propensity to polymerize to form wavy filaments, which do not share the characteristics of cross-beta amyloid fibrils. Moreover, we provide evidence for the inhibition of ApoE4 fibril formation by ApoE3. This study shows that recombinant ApoE isoforms show no significant differences at the structural or conformational level. However, self-assembly of the ApoE4 isoform may play a role in pathogenesis, and these results open opportunities for uncovering new triggers for AD onset. (C) 2019 Published by Elsevier Ltd.
引用
收藏
页码:2248 / 2265
页数:18
相关论文
共 50 条
  • [41] Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer's disease
    Najm, Ramsey
    Jones, Emily A.
    Huang, Yadong
    MOLECULAR NEURODEGENERATION, 2019, 14 (1)
  • [42] Apolipoprotein E4: A causative factor and therapeutic target in neuropathology including Alzheimer's disease
    Mahley, RW
    Weisgraber, KH
    Huang, YD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (15) : 5644 - 5651
  • [43] Plasma cholesterol and risk for late-onset Alzheimer's disease
    Cedazo-Minguez, Angel
    Ismail, Muhammad-Al-Mustafa
    Mateos, Laura
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (04) : 495 - 498
  • [44] Apolipoprotein E4 allele and ribosomal genes in Alzheimer's disease
    Tavares, WM
    Sperança, MA
    de Labio, RW
    Peres, CA
    Okamoto, IH
    Bertolucci, PHF
    Smith, MD
    Payao, SLM
    JOURNAL OF ALZHEIMERS DISEASE, 2004, 6 (04) : 391 - 395
  • [45] Apolipoprotein E4 and Alzheimer's disease: In Sao Paulo - Brazil
    Almeida, OP
    Shimokomaki, CM
    ARQUIVOS DE NEURO-PSIQUIATRIA, 1997, 55 (01) : 1 - 7
  • [46] Aβ-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease
    Huang, Yadong
    TRENDS IN MOLECULAR MEDICINE, 2010, 16 (06) : 287 - 294
  • [47] The impact of apolipoprotein E4 on cause of death in Alzheimer's disease
    Olichney, JM
    Sabbagh, MN
    Hofstetter, CR
    Galasko, D
    Grundman, M
    Katzman, R
    Thal, LJ
    NEUROLOGY, 1997, 49 (01) : 76 - 81
  • [48] Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
    Ramsey Najm
    Emily A. Jones
    Yadong Huang
    Molecular Neurodegeneration, 14
  • [49] Apolipoprotein E4 as a Novel Treatment Target for Alzheimer's Disease
    Jervies, Jamieson Lachlan
    King, Samuel Peter
    Suphioglu, Cenk
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2021, 55 (06) : 773 - 783
  • [50] Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer's disease
    Poirier, J
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1999, 24 (02): : 147 - 153